Reuters Health via Consultant 360 reports on a new study by Swiss researchers that found early administration of high-dose erythropoietin (EPO) appears to reduce the likelihood of brain MRI abnormalities in preterm infants. Boston Children’s Shenandoah Robinson, MD provides comment on the study results, and concludes, “treatments like EPO or similar agents for preterm infants could have a tremendous impact globally, as prematurity not only increases lifelong medical needs but also in many cases limits economic productivity in adults."
The Boston Globe reports that Boston Children’s Ben Warf, MD, has been named a 2012 MacArthur Foundation Fellow, one of four Boston-area recipients of the “genius grant.” The award comes with a $500,000 stipend, and, for Warf, visibility for hydrocephalus - a global health problem that he said has been “way under the radar.” The New York Times, Boston.com’s “Culture Desk” blog and Harvard Gazette also report on the award.
Mark Proctor, MD appears in The Boston Globe's Health Answers
Boston Children's pediatric neurosurgeon Mark Proctor, MD answered a reader's question about plagiocephaly in The Boston Globe. The question and answer also appeared on Boston.com.